Research study Program year 2019 Source: CMS Open Payments

BI 730357 - Psoriasis Long-Term Extension

Research payments

$26,479

55 payments

Through program year 2019, $26,479 in research payments was reported against BI 730357 - Psoriasis Long-Term Extension, across 55 payments, paid by Boehringer Ingelheim Pharma GmbH & Co.KG.

Paid by: Boehringer Ingelheim Pharma GmbH & Co.KG
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2019	Research	$26,479	55

Breakdown

Who paid Research payments · program year 2019

Boehringer Ingelheim Pharma GmbH & Co.KG $26,479 55 payments

Who received the money Research payments · program year 2019

Dermatology Rsrch Associates Organisation paid for research $6,227 6 payments
Southern California Dermatology Organisation paid for research $4,764 4 payments
Ctr For Clinical Studies Organisation paid for research $2,955 9 payments
Atlanta Dermatology Vein And Research Center LLC Organisation paid for research $1,520 4 payments
Total Skin And Beauty Dermatology Center Organisation paid for research $1,494 5 payments
Psoriasis Treatment Ctr Of Ctrl New Jersey Organisation paid for research $1,207 3 payments
Menter Dermatology Rsrch Inst Organisation paid for research $1,207 5 payments
Clinical Partners Organisation paid for research $1,199 4 payments
Crcc LLC Organisation paid for research $999 3 payments
Health Concepts Organisation paid for research $979 3 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.